Rehmann Capital Advisory Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Rehmann Capital Advisory Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,248	Closed	-$75.1K	–	1997
2019 Q2	$75.1K	Hold	1,248	–	–	0.01%	701
2019 Q1	$81.3K	Buy	+1,248	New	+$82K	0.01%	656
2018 Q4	–	Sell	-1,248	Closed	-$91.7K	–	2042
2018 Q3	$91.7K	Hold	1,248	–	–	0.01%	603
2018 Q2	$83.9K	Hold	1,248	–	–	0.01%	606
2018 Q1	$78K	Buy	+1,248	New	+$82.2K	0.01%	616

Other funds holding PJP

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Rehmann Capital Advisory Group's PJP Position: Q3 2019 in Review

Rehmann Capital Advisory Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2019, closing a stake of 1,248 shares — an estimated $75.1K sold.

Rehmann Capital Advisory Group first reported a position in PJP in Q1 2018 and held it in 5 quarters. The position peaked at $91.7K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q3 2019.

Rehmann Capital Advisory Group reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2019 after selling out during the quarter.
Rehmann Capital Advisory Group sold 1,248 Invesco Pharmaceuticals ETF shares in Q3 2019, an estimated $75.1K.
Rehmann Capital Advisory Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2018 and held it in 5 quarters.
Rehmann Capital Advisory Group's Invesco Pharmaceuticals ETF position peaked at $91.7K in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.